Aug 2026· Revista Inclusiones· Vol 13, pp. e4003· 0 citations
TL;DR
Overall, AI emerged as a key driver of innovation in oncological palliative care as well as a strategic tool for supporting decision-making within health systems and identifying emerging technological trajectories.
Abstract
Patent mapping is a strategic tool for supporting decision-making within health systems and identifying emerging technological trajectories. In oncology, the growing demand for palliative care, coupled with rising treatment costs, has intensified interest in artificial intelligence (AI)-based solutions. This study reviewed patents published during the preceding five-year period to characterize AI-related technological trends in oncology, with particular emphasis on their clinical applications and economic implications. Patent searches were conducted in the databases of the Brazilian National Institute of Industrial Property, Espacenet, and the World Intellectual Property Organization between September and December 2025, using the search terms “Palliative Care” and “Cancer,” together with the International Patent Classification code G16H10/60. Of the 251 patents initially identified, 19 met the predefined eligibility criteria. The protected technologies included risk prediction models, clinical decision support systems, symptom-monitoring platforms, and natural language processing tools. These innovations were designed to improve prognostic accuracy, facilitate referrals to palliative care services, and optimize the allocation of healthcare resources. Overall, AI emerged as a key driver of innovation in oncological palliative care.
Artificial intelligence research in pancreatic cancer is growing rapidly and becoming increasingly multidisciplinary, although productivity and collaboration remain uneven.
Pegah Rashidian, A. Smerat, Mohammad Ahmar Khan et al.· Medicine· 0 citations
BACKGROUND
Infectious Diseases require rapid decisions based on heterogeneous and evolving clinical data. At the same time, the shortage of infectious diseases specialists continues to widen the gap between demand for expertise and its availability. Artificial intelligence (AI) has emerged as a potential support tool,...
Fabio Borgonovo, F. Pennisi, Francesco Petri et al.· Clinical Microbiology and In...· 1 citation
This review examines current applications of LLMs to health economic modeling in terms of reproducibility, validation, adaptability, and technology readiness and concludes that near-term gains are augmenting human modelers on decomposed, verifiable sub-tasks rather than pursuing autonomous end-to-end modeling.
Attila Imre, B. Németh, Á. Jóźwiak et al.· Expert review of pharmacoeco...· 0 citations
The study concludes that evidence-based, auditable, locally adaptable, locally adaptable, and supervised by licensed clinician retrieval systems with generative AI can support safer, faster, and more relevant decision-making processes in clinical settings.
Sonam Kumari· International Journal of Adv...· 0 citations
Although challenges related to data governance, interoperability, ethical oversight, and workforce preparedness remain, responsible AI adoption supported by robust regulatory frameworks will be critical for sustaining long-term value.
Upendra Nagaich· Journal of Pharmaceutical Te...· 0 citations
Artificial intelligence (AI) has expanded rapidly across the oncology continuum—spanning early detection, histopathology, molecular profiling, treatment selection, drug discovery, toxicity surveillance, and survivorship care. However, these varied applications occupy fundamentally different stages of clinical and biolo...
S. K. Kuchana, Nikhilesh V. Alahari, Rohith Kode et al.· Molecular Cancer· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.